Dilated Cardiomyopathy (dcm) Clinical Trials
4 recruiting trials for Dilated Cardiomyopathy (dcm). Eligibility criteria explained in plain English.
TrialFinderData lists 4 Dilated Cardiomyopathy (dcm) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Chinese Academy of Medical Sciences, Fuwai Hospital (1), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1), University Hospital, Essen (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Magnetic Resonance Imaging with Contrast (diagnostic_test, 1 trial), followed by Immunoadsorption, Support treatment, cardiac medical treatment, aetiology-specific treatment, device implant, arrhythmia ablation.
Track Dilated Cardiomyopathy (dcm) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Application of T1 Mapping in Real-World
The goal of this observational study is to create a comprehensive real-world spectrum of T1 mapping measurements across different heart conditions. We aim to establish reference...
Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)
This study is a multicenter, dual-arm and randomized controlled clinical trial. Sixty patients with dilated cardiomyopathy and positive β1-adrenergic receptor autoantibodies were...
Multimodal Analysis of Endomyocardial Biopsies
The goal of this observational study is to pursue a multimodal approach to identify the molecular signatures and immune signalling molecules of various myocardial diseases and...
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients...
Non-ischemic cardiomyopathies (NICM) represent a heterogeneous group of pathologies characterized by absence of obstructive disease of the epicardial coronary vessels and distinct...
Explore Other Conditions
Frequently Asked Questions
There are currently 4 clinical trials for Dilated Cardiomyopathy (dcm), with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Dilated Cardiomyopathy (dcm), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Dilated Cardiomyopathy (dcm), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.